| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/30/2014 | EP2723869A1 An il-15 and il-15r sushi domain based immunocytokines |
| 04/30/2014 | EP2723773A1 Removal of target cells by circulating virus-specific cytotoxic t-cells using mhc class i comprising complexes |
| 04/30/2014 | EP2723772A1 Immunoglobulin single variable domains directed against ige |
| 04/30/2014 | EP2723771A1 Serum albumin binding proteins |
| 04/30/2014 | EP2723770A2 Fc variants with reduced effector functions |
| 04/30/2014 | EP2723769A2 Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains |
| 04/30/2014 | EP2723764A2 Binding domains directed against gpcr:g protein complexes and uses derived thereof |
| 04/30/2014 | EP2723759A1 Purification of chimeric protein |
| 04/30/2014 | EP2723380A1 Light chain immunoglobulin fusion proteins and methods of use thereof |
| 04/30/2014 | EP2723377A1 Anti-axl antibodies and uses thereof |
| 04/30/2014 | EP2723376A1 Anti-axl antibodies and uses thereof |
| 04/30/2014 | DE112012000439T5 Stammzellfaktor-Inhibitor Stem cell factor inhibitor |
| 04/30/2014 | CN1997670B Human anti-KIR antibodies |
| 04/30/2014 | CN103765220A Marker for detecting colorectal cancer or esophageal cancer and method for inspecting same |
| 04/30/2014 | CN103764826A Receptor gene for peptide cancer antigen-specific t cell |
| 04/30/2014 | CN103764825A Cancer treatment and/or prevention drug composition |
| 04/30/2014 | CN103764681A Bispecific antigen binding molecules |
| 04/30/2014 | CN103764680A Anti-human XCR1 antibodies |
| 04/30/2014 | CN103764679A Neutralizing prolactin receptor antibody Mat3 and its therapeutic use |
| 04/30/2014 | CN103764678A c-Met antibody combinations |
| 04/30/2014 | CN103764677A Anti-nerve growth factor antibodies and methods of preparing and using the same |
| 04/30/2014 | CN103764676A Fusion gene of KIF5B gene and RET gene, and method for determining effectiveness of cancer treatment targeting fusion gene |
| 04/30/2014 | CN103764665A Using sortases to install click chemistry handles for protein ligation |
| 04/30/2014 | CN103764170A Novel binder-drug conjugates (ADCs) and their use |
| 04/30/2014 | CN103756973A Indirect ELISA (enzyme linked immunosorbent assay) detection kit for grass carp reoviruses |
| 04/30/2014 | CN103755809A Antibodies for treating and diagnosing tumors expressing SLC34A2(TAT211=SEQID2) |
| 04/30/2014 | CN103755808A Novel anti-alpha5beta1 antibodies and uses thereof |
| 04/30/2014 | CN103755807A Specific binding agents to hepatocyte growth factor |
| 04/30/2014 | CN103755806A Monoclonal antibody for resisting Myxobolus honghuensis Liu et Gu shell valve protein and application of monoclonal antibody |
| 04/30/2014 | CN103755805A Human monoclonal antibody with HIV-1 Env specificity |
| 04/30/2014 | CN103755804A Nano antibody for type A H3N2 influenza virus and application thereof |
| 04/30/2014 | CN103755803A H5N1 subtype avian influenza virus NS1 protein polyclonal antibody, and preparation method and application thereof |
| 04/30/2014 | CN103755802A Synthesis method of structurally specific salbutamol complete antigen |
| 04/30/2014 | CN103751780A KIM-1 antibodies for treatment of TH2-mediated conditions |
| 04/30/2014 | CN103215652B Aflatoxin positive antibody gene bank, establishing method and application thereof, and aflatoxin recombinant single-chain antibody 1A7 |
| 04/30/2014 | CN103215230B Hybridoma cell strain AFM1B7, monoclonal antibody thereof and aflatoxin M1 flow lag immunization time-resolved fluorescence quick test kit |
| 04/30/2014 | CN103215229B Hybridoma cell strain AFB3G1, monoclonal antibody thereof and multi-detection line immunochromatography test strip for semi-quantitatively detecting aflatoxin B1 |
| 04/30/2014 | CN103131771B C1q gene and application of coding protein of C1q gene |
| 04/30/2014 | CN103130892B Aflatoxin recombination single-chain antibody 2G7, encoding gene and application thereof |
| 04/30/2014 | CN102712673B Chromatographic method for purifying FC-containing proteins |
| 04/30/2014 | CN102675602B Biomimetic monolithic material with affine selectivity similar to that of protein A and preparation method and application thereof |
| 04/30/2014 | CN102448493B Treatment of insulin-resistant disorders |
| 04/30/2014 | CN102443060B Anti-HPV (human papilloma virus) antibody and preparation method and application thereof |
| 04/30/2014 | CN101985471B Folate-IgG conjugate as well as preparation method and application thereof |
| 04/30/2014 | CN101925364B 14-3-3 antagonists for prevention and treatment of arthritis |
| 04/30/2014 | CN101875697B Design of novel anti-EGFR humanized antibody TGM10 and application thereof |
| 04/30/2014 | CN101724075B Remodeling and glycoconjugation of peptides |
| 04/30/2014 | CN101360826B Anti-alpha2 integrin antibodies and their uses |
| 04/29/2014 | US8710203 Therapeutic human anti-IL-1R1 monoclonal antibody |
| 04/29/2014 | US8710202 Isolated nucleic acid molecule encoding an antibody that reduces GDF-8 activity |
| 04/29/2014 | US8710196 Protein purification |
| 04/29/2014 | US8710194 Single-chain variable fragment (scFv) able to recognize and bind CD99 human protein |
| 04/29/2014 | US8710193 Antibody recognizing turn structure in amyloid β |
| 04/29/2014 | US8710192 PCSK9 antagonists |
| 04/29/2014 | US8710191 Antibodies to CCR2 |
| 04/29/2014 | US8710190 Human embryonic stem cell methods and PODXL expression |
| 04/29/2014 | US8710189 Anti-FGFR3 antibodies and methods using same |
| 04/29/2014 | US8710183 Inhibitors of bacterial tyrosine kinase and uses thereof |
| 04/29/2014 | US8710181 Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins |
| 04/29/2014 | US8710180 VEGF-specific capture agents, compositions, and methods of using and making |
| 04/29/2014 | US8710014 Compositions and methods for inhibition of MMP13:MMP-substrate interactions |
| 04/29/2014 | US8709998 Peptide vectors |
| 04/29/2014 | US8709827 Polypeptide microparticles |
| 04/29/2014 | US8709813 DNA promoters and anthrax vaccines |
| 04/29/2014 | US8709779 Newly identified human rhinovirus of HRV-C and methods and kits for detecting HRV-Cs |
| 04/29/2014 | US8709759 Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins |
| 04/29/2014 | US8709756 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 04/29/2014 | US8709492 Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals |
| 04/29/2014 | US8709437 Clostridium chauvoei polypeptide, DNA encoding the polypeptide and a vaccine comprising the polypeptide |
| 04/29/2014 | US8709436 Polypeptides and immunizing compositions containing gram positive polypeptides and methods of use |
| 04/29/2014 | US8709431 Enediyne compounds, conjugates thereof, and uses and methods therefor |
| 04/29/2014 | US8709430 Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids |
| 04/29/2014 | US8709428 Antibodies to Clostridium difficile toxins |
| 04/29/2014 | US8709427 Assay for the diagnosis of flaviviral infection using antibodies with high affinity for NS1 protein of flavivirusi in hexameric form |
| 04/29/2014 | US8709426 Nucleotide sequence coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses |
| 04/29/2014 | US8709425 Antibodies to non-functional P2X7 receptor |
| 04/29/2014 | US8709424 Anti-GITR antibodies |
| 04/29/2014 | US8709422 Methods and compositions to treat and detect misfolded-SOD1 mediated diseases |
| 04/29/2014 | US8709418 Pharmaceutical composition for treating CAPRIN-1 expressing cancer |
| 04/29/2014 | US8709409 Method for treating rheumatoid arthritis by administering an anti-IL-6 antibody and methotrexate |
| 04/29/2014 | CA2534907C Homogeneous preparations of il-28 and il-29 |
| 04/29/2014 | CA2408571C Mammalian receptor proteins; related reagents and methods |
| 04/24/2014 | WO2014062963A1 Methods and compositions relating to anti-il-21 receptor antibodies |
| 04/24/2014 | WO2014062245A2 Antigen binding proteins that bind dll-4 |
| 04/24/2014 | WO2014061783A1 Human antibody specific to toxin produced from clostridium difficile, or antigen-binding fragment thereof |
| 04/24/2014 | WO2014061411A1 Cation exchange chromatography carrier for refining of antibodies, and method for separation of antibody monomers from polymers thereof produced in antibody drug manufacturing process |
| 04/24/2014 | WO2014061277A1 Antibody-drug conjugate produced by binding through linker having hydrophilic structure |
| 04/24/2014 | WO2014060712A1 Immunomodulatory proteins |
| 04/24/2014 | WO2014060444A1 Antibodies to amyloid beta |
| 04/24/2014 | WO2014060365A1 Bispecific her2 ligands for cancer therapy |
| 04/24/2014 | WO2014060210A1 Methods and compositions for the treatment of pancreatic cancer |
| 04/24/2014 | WO2014059541A1 Novel cell wall deconstruction enzymes of thermoascus aurantiacus, myceliophthora fergusii (corynascus thermophilus), and pseudocercosporella herpotrichoides, and uses thereof |
| 04/24/2014 | WO2014033158A3 Pcsk9 peptide vaccine |
| 04/24/2014 | WO2013192550A3 Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof |
| 04/24/2014 | WO2013185193A8 Method for producing and obtaining variable domains of anti-digoxin monoclonal antibody fab fragment using the molecular biology cloning technique |
| 04/24/2014 | WO2013049362A8 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis |
| 04/24/2014 | WO2013033249A3 Neutron irradiation therapy device |
| 04/24/2014 | WO2012112690A3 Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains |
| 04/24/2014 | US20140115729 Apoptotic anti-ige antibodies |
| 04/24/2014 | US20140115727 NOVEL ANTI-cMET ANTIBODY |